Agios Pharmaceuticals | AGIO - Рыночная капитализация





Рыночная капитализация Изменить Дата
AbbVie USD 364.22B 20.46B 2026-05
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Arrowhead Research USD 9.7B 920M 2026-05
Astellas Pharma JPY 4.56T 770.92B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Bayer EUR 37.69B 1.01B 2026-05
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Exelixis USD 14.34B 3.44B 2026-05
Gilead Sciences USD 167.39B 5.6B 2026-05
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Incyte USD 21.73B 3B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Novartis USD 232.75B 75B 2026-05
Pfizer USD 147.4B 6.42B 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.16B 123M 2026-05
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05